Growth hormone in vascular pathology: Neovascularization and expression of receptors is associated with cellular proliferation

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4201-4218

  Lincoln, David T ^a   Singal, P K ^b   Al Banaw, A ^c  

^a Independent Research Foundation   (Australia)

^b UNIVERSITY OF MANITOBA   (Canada)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cellular proliferation; Growth hormone; Growth hormone receptor; Vascular tumours

Indexed keywords

FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOGENESIS; ANGIOSARCOMA; ARTICLE; CELL PROLIFERATION; DISEASE ASSOCIATION; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPOSI SARCOMA; MALE; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CELL GROWTH PROCESSES; FEMALE; GROWTH HORMONE; HEMANGIOMA; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; RATS; RECEPTORS, SOMATOTROPIN; VASCULAR NEOPLASMS;

EID: 37549047525     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Longati P, Comoglio PM and Bardelli A: Receptor tyrosine kinases as therapeutic targets: The model of the MET oncogene. Current Drug Targets 2: 41-55, 2001.
2. Green H, Morikawa M and Nixon T: A dual effector theory of growth hormone action. Differentiation 29: 195-198, 1985.
3. Isaksson OG, Lindahl A, Nilsson A and Isgaard J: Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Rev 8: 426-438, 1987.
4. Mathews LS, Norstedt G and Palmiter RD: Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Sci USA 83: 9343, 1986.
5. Mathews LS, Enberg B and Norstedt G: Regulation of rat growth hormone receptor gene expression. J Biol Chem 264: 9905-9910, 1989.
6. Hynes MA, Van Wyk J, Brooks PJ, D'Ercole AJ and Lund PK: Growth hormone dependence of somatomedin C-insulin like growth factor I and insulin like growth factor II messenger ribonucleic acids. Mol Endocrinology 1: 233-242, 1987.
7. Murphy LJ, Bell GI and Friesen HG: Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo. Endocrinol 120: 1806-1812, 1987.
8. Waters MJ: The growth hormone receptor. In: Handbook of Physiology, Oxford University Press, JL Kostyo (eds.), 1996.
9. Lincoln DT, Waters MJ, Breipohl W, Sinowatz F and Lobie P: Growth hormone receptor expression in proliferating rat mammary gland. Acta Histochem Suppl. 40: 47-49, 1990.
10. Lincoln D, Berger H, Breipohl W, Hifnawi E, Waters M and Lobie P: Growth hormone receptor localization in primary human melanomas. Arch Dermatol Res 283: 64, 1991.
11. Lincoln DT, Breipohl W and Wegener A: Immunohistochemical demonstration of growth hormone receptors (GH-R) in stromal cells from long-term human bone marrow cultures (LTBMC). Histochem J 24: 626-627, 1992.
12. Lincoln DT, El-Hifnawi E, Sinowatz F and Waters MJ: Immunohistochemical localization of growth hormone receptor binding protein in the mammalian cerebellum. Ann Anatomy 176: 419-427, 1994.
13. Lincoln DT, Sinowatz F, El-Hifnawi E, Hughes RL and Waters MJ: Evidence of a direct role for growth hormone in mammary gland proliferation and lactation. Anat Histol Embryol 24: 107-115, 1995.
14. Lincoln DT, Temmim L, Al-Jarallah MA, Mathew TC and Dashti H: Primary Ki-1 lymphoma of the skin: expression of growth hormone receptors. Nutrition Suppl 11: 627-631, 1995.
15. Lincoln DT, Temmim L, Al-Jarallah MA, Lobie PE:Growth hormone receptors in human keratinocyte cells. Kuwait Medical Journal 10: 86-93, 1995.
16. Lincoln DT, Temmim L, Al-Jarallah MA, Lincoln JD and Mathew TC: Tumour Stromal Cell Progenitors Adapt to Tumour Growth. In: Adaptation Biology and Medicine, Volume 1, Subcellular Level. Sharma BK, Takeda N, Ganguly NK, Singal PK (eds.). Narosa Publishing House, New Delhi, Chapter 29, pp. 299-314, 1997.
17. Lincoln DT, Sinowatz F, Gabius H, Gabius S, Baker H and Mathew C: Subpopulations of stromal cells from long-term human bone marrow cultures: ontogeny of progenitor cells and expression of growth hormone receptors. Anat Hist Embryol 26: 11-28, 1997.
18. Lincoln DT, Sinowatz F, Temmim-Baker L, Baker HI, Kölle S and Waters MJ: Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol 109: 141-159, 1998.
19. Lincoln DT, Sinowatz F, Kölle S, Parsons P and Waters MJ: Up-regulation of growth hormone receptor immunoreactivity in human melanoma. Anticancer Res 19: 19919-1932, 1999.
20. Lincoln DT, Snyder JR, Sinowatz F and Waters MJ: Adaptation of growth hormone receptor expression to tumour growth. In: Adaptation Biology and Medicine, Volume 2, Pandolf KB, Takeda N, Singal PK (eds.). Narosa Publishing House, New Delhi, Chapter 19, pp. 119-138, 1999.
21. Lincoln DT, Kaiser HE, Raju GP and Waters MJ: Growth hormone and colorectal carcinoma: Localization of receptors. In Vivo 14: 41-50, 2000.
22. Lincoln DT, Kaiser HE, Abul HT and Al-Jarallah MA: Vascular stroma-derived endothelial colony forming progenitor cells adapt to tumour growth. In Vivo 16: 1-14, 2002.
23. Lincoln DT and West P: Growth hormone receptor expression in the central nervous system. Journal of Anatomy 168: 55, 2002.
24. Lincoln DT, Abul HT and Al-Khaledi M: Breast cancer and growth hormone: Receptor expression in young Kuwaiti women. Annals of Anatomy 185(Suppl.): 94, 2003.
25. Lincoln D T, Singal PK, Al-Khaledi M, Al-Yatama F and Mohammed FM: Clinicopathological aspects and risk factors of breast cancer: Adaptation of biologically agressive carcinomas in young Arab women. In: Adaptation Biology and Medicine, Volume 5, Health Potentials, Lukyanova L, Takeda N, Singal PK (eds.). Narosa Publishing House, New Delhi, Chapter 17, pp. 211-244, 2007.
26. Sinowatz F, Breipohl W, Waters MJ, Lincoln DT, Lobie PE and Amselgruber W: Growth hormone receptor expression in the Dunning R 3327 prostatic carcinoma of the rat. Prostate 19: 273-278, 1991.
27. Sinowatz, F, Schams D, Kölle S, Plath A, Lincoln D and Waters MJ: Cellular localization of growth hormone receptor in the bovine mammary gland during mammogenesis, lactation and involution. J Endocrinology 166: 503-510, 2000.
28. Barnard R, Mulcahy J, Garcia-Aragon J and Wyse B: Serum growth hormone binding protein and hepatic GH binding sites in the Lewis dwarf rat: effects of IGF-1 and GH. Growth Regulation 4: 147-154, 1994.
29. Werther GA, Haynes KM, Barnard R and Waters M: Visual demonstration of GH receptors on human growth plate chondrocytes. J Endo Metab 70: 1725-1731, 1990.
30. Brennan JW, Midha R, Ang LC and Perez-Ordonez B: Epithelioid hemangioendothelioma of the spine presenting as cervical myelopathy: case report. Neurosurgery 48: 1166-1169, 2001.
31. Nishimoto H and Norihiro T: Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman's disease. Blood 106: 2627-2632, 2005.
32. Kim JE, Kim CJ, Park IA and Kim WH: Clinicopathologic study of Castleman's disease in Korea. J Korean Med Sci 15: 393-398, 2000.
33. Du, M Q, Liu H, Diss TC, Ye H and Hamoudi RA: Kaposi's sarcoma associated herpes virus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman's disease and associated lymphoproliferative disorders. Blood 97: 2130-2136, 2001.
34. Sirvent JJ, Santage M, Salvado M, Alvaro T, Raventos A and Palacios J: Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer, relationship between differentiation, degree and axillary lymph node metastases. Histol Histopathol 9: 563-570, 1994.
35. Bacus S, Goldschmidt R, Chin D, Moran G and Weinberg D: Biological grading of breast cancer using antibodies to proliferating cells and other markers. Am J Pathol 135: 783-792, 1998.
36. Bacus S, Zelnick CR, Plowman G and Yaeden Y: Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancer. Am J Clin Pathol 102: S13-S24, 1994.
37. Barbareschi M, Leonardi F and Mauri F: p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlation with receptor status, proliferation markers and clinical stage in human breast cancer. Am J Clin Pathol 98: 408-418, 1992.
38. Vanlemmens L, Hebbar M, Peyrat J and Bonneterre J: Age as a prognostic factor in breast cancer. Anticancer Res 18: 1891-1896, 1998.
39. Sakr WA, Sarkar FH, Sreepathi P, Drozdowicz S and Crissman JD: Measurement of cellular proliferation in human prostate by AgNOR, PCNA and SPF. Prostate 22: 147-154, 1993.
40. Cher M, Chew K, Rosenau W and Carroll P: Cellular proliferation in prostatic carcinoma as assessed by bromodeoxyuridine uptake, Ki-67, PCNA expression. Prostate 26: 87-93, 1995.
41. Leong A, Milios J and Tang S: Is immuno-localisation of proliferating cell nuclear antigen (PCNA) in paraffin sections a valid index of cell proliferation? Appl Immunohistchem 1: 127-135, 1993.
42. Simpson JF and Page DL: Status of breast cancer prognostication based on histopathologic data. Am J Clin Pathol 102: S3-S8, 1994.
43. Charpin C, Andrac L and Vacheret H: Multiparametric evaluation of growth fraction (Monoclonal Ki-67) in breast carcinoma tissue sections. Cancer Res 48: 4368, 1988.
44. Iatropoulos M and Williams G: Proliferation markers. Exp Toxicol Pathol 48: 175-181, 1996.
45. Bouzzubar N, Walker RJ and Griffiths K: Ki-67 immunostaining in primary breast cancer. Pathological and clinical associations. Br J Cancer 59: 943, 1989.
46. Brown RW, Allered DC and Clark G: Prognostic significance and clinical pathological correlations of cell cycle measured by Ki-67 immunocytochemistry in axillary node negative carcinoma of the breast. Breast Cancer Res Treat 16: 191, 1990.
47. Brown RS and Wahl R: Overexpression of glut-1 glucose transporter in human cancer. Cancer 72: 2979-2985, 1993.
48. Haarrslev T, Jacobson G and Zedeler K: Correlation of growth fraction by Ki-67 and proliferating nuclear antigen immuno-histochemistry with histopathological parameters and prognosis in primary breast cancer. Breast Cancer Res Treat 37: 101-113, 1996.
49. Vesalainen T, Lipponen PK, Talja MT, Alhava EM and Syrjanen KJ: Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2MO prostatic adenocarcinoma. Int J Cancer 58: 303-303, 1994.
50. Jonsson ZO and Hubscher U: Proliferating cell nuclear antigen: more than a clamp for DNA polymerases. Bioessays 19: 967-975, 1997.
51. Visakorpi T: Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 168: 7-13, 1992.
52. McNeal JE, Haillot O and Yemoto C: Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate 27: 258-268, 1995.
53. Cappello F, Palma A, Martorana A, Rappa F, Cabibi D and Barresi E: Biological aggressiveness evaluation in prostate carcinoma: immunohistochemical analysis of PCNA and p53 in a series of adenocarcinomas. Eur J Histochem 47: 129-132, 2003.
54. Schonborn I, Minguillon C, Lichtenegger W, Zschiesche W and Spitzer E: The prognostic significance of recent tumour markers for lymph node negative breast cancer. Geburtshilfe Frauenheilkunde 55: 566-571, 1995.
55. Asakava K, Heda JA, McElduff A, Rouiller DG, Waters, MJ and Gordon P: The human growth hormone receptor of cultured human lymphocytes. Biochem J 238: 379-386, 1986.
56. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenecies and metastasis correlation in invasive breast carcinoma. New Engl J Med 324: 1-8, 1991.
57. Weidner N, Folkman J and Pozza F: Tumor angiogenecies: A new significant and independent prognostic indicator in early-stage breast carcinoma. JNCI 84: 1875-1887, 1992.
58. Fuh G, Cunningham BC, Fukunaga S, Nagata S, Goeddel DV and Wells JA: Rational design of potent antagonists to the human growth hormone receptor. Science 256: 1677-1680.
59. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW and Waters MJ: A model for GH receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12: 814-821, 2005.
60. Woelfe J, Chia DJ and Rotwein P: Mechanisms of growth hormone action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor 1 gene activation. J Biol Chem 278: 1261-1266, 2003.
61. Woelfe J, Billiard J and Rotwein P: Acute control of IGF-1 gene transcription by growth hormone through Stat5b. J Biol Chem 278: 22696-22702, 2003.
62. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H and Tepper A: Growth hormone insensitivity associated with a STAT5b mutation. New Engl J Med 349: 1139-1147, 2003.
63. Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA and Brown RJ: New insights into growth hormone action. J Mol Endocrinology 36: 1-7, 2006.
64. Bowman T, Garcia R, Turkson J and Jove R: STATs in oncogenesis. Oncogene 19: 2474-2488, 2000.
65. Somerville L and Cory JG: Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res 20: 3347-3355, 2000.
66. Turkson J and Jove R: STAT proteins: Novel molecular targets for cancer drug discovery. Oncology 19: 6613-6626, 2000.